These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24271466)

  • 1. An in vitro method of evaluating tolnaftate release from topical powder.
    Viegas TX; Kibbe AH; Hikal AH; Cleary RW; Jones AB
    Pharm Res; 1986 Apr; 3(2):88-92. PubMed ID: 24271466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A liquid chromatographic method for the determination of tolnaftate in pharmaceutical formulations.
    Dash AK
    J Pharm Biomed Anal; 1993 Sep; 11(9):847-53. PubMed ID: 8218531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic efficacy of a topical tolnaftate preparation in guinea pig model of tinea pedis].
    Yamaguchi H; Uchida K; Tanaka T; Yamaguchi T
    Jpn J Antibiot; 2001 Jun; 54(6):323-30. PubMed ID: 11521512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.
    Loock JW
    Clin Otolaryngol; 2012 Aug; 37(4):261-70. PubMed ID: 22804826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of tinea pedis. Efficacy of tolnaftate powder and its talc-cornstarch base.
    Burrill BB; Nemlick AS
    J Med Soc N J; 1970 Oct; 67(10):629-31. PubMed ID: 4920842
    [No Abstract]   [Full Text] [Related]  

  • 6. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Drug Release from Manipulated Abuse Deterrent Formulations.
    Feng X; Zidan A; Kamal NS; Xu X; Sun D; Walenga R; Boyce H; Cruz CN; Ashraf M
    AAPS PharmSciTech; 2020 Jan; 21(2):40. PubMed ID: 31897805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the topical tolnaftate delivery for the treatment of tinea pedis via provesicular gel systems.
    AbouSamra MM; Salama AH
    J Liposome Res; 2017 Dec; 27(4):324-334. PubMed ID: 27666873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pastes: what do they contain? How do they work?
    Juch RD; Rufli T; Surber C
    Dermatology; 1994; 189(4):373-7. PubMed ID: 7873823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolnaftate powder in prophylaxis of tinea pedis.
    Smith EB; Dickson JE; Knox JM
    South Med J; 1974 Jul; 67(7):776-8. PubMed ID: 4600407
    [No Abstract]   [Full Text] [Related]  

  • 11. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
    Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
    AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tolnaftate powder in the treatment and prophylaxis of foot mycoses.
    Balogh E; Nagy E; Mészáros C
    Ther Hung; 1988; 36(2):86-7. PubMed ID: 3201392
    [No Abstract]   [Full Text] [Related]  

  • 13. A Natural Cream-to-Powder Formulation Developed for the Prevention of Diaper Dermatitis in Diaper-Wearing Infants and Children: Barrier Property and In-Use Tolerance Studies.
    Gunt HB; Levy SB; Lutrario CA
    J Drugs Dermatol; 2018 May; 17(5):566-570. PubMed ID: 29742190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of fast dissolving flurbiprofen and esomeprazole solid dispersion using spray drying technique.
    Pradhan R; Tran TH; Kim SY; Woo KB; Choi YJ; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2016 Apr; 502(1-2):38-46. PubMed ID: 26899979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
    Kim S; Eum J; Yang H; Jung H
    J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CLINICAL EVALUATION OF ZEASORB POWDER IN PODIATRY.
    WEINSTOCK BS
    J Am Podiatry Assoc; 1965 May; 55():350. PubMed ID: 14324337
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of gelatin-acacia coacervate containing benzocaine in topical formulations.
    Ichwan AM; Karimi M; Dash AK
    J Pharm Sci; 1999 Aug; 88(8):763-6. PubMed ID: 10430539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
    Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2% Miconazole nitrate powder in aerosol spray form: its efficacy in treating tinea pedis.
    Shellow WV
    J Int Med Res; 1982; 10(1):28-31. PubMed ID: 7060822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of particle size on mixing degree in dispensation.
    Nakamura H; Yanagihara Y; Sekiguchi H; Ohtani M; Kariya S; Uchino K; Suzuki H; Iga T
    Yakugaku Zasshi; 2004 Mar; 124(3):135-9. PubMed ID: 15049131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.